Tokyo Tape
Sign in
← Pharmarise Holdings

Quarterly report · Q1

2796.TEDINET S100S04W
Period2023-06-01 → 2023-08-31
Filed2023-10-11
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥13.5bn2023-06-01 → 2023-08-31Cons.Net sales
Revenue¥52.0bn2022-06-01 → 2023-05-31Cons.Net sales (5-year summary)
Revenue¥12.9bn2022-06-01 → 2022-08-31Cons.Net sales
Operating income¥331m2023-06-01 → 2023-08-31Cons.Operating income
Operating income¥348m2022-06-01 → 2022-08-31Cons.Operating income
Ordinary income¥331m2023-06-01 → 2023-08-31Cons.Ordinary income
Ordinary income¥1.4bn2022-06-01 → 2023-05-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥341m2022-06-01 → 2022-08-31Cons.Ordinary income
Profit before tax¥312m2023-06-01 → 2023-08-31Cons.Income before income taxes
Profit before tax¥318m2022-06-01 → 2022-08-31Cons.Income before income taxes
Net income (owners)¥123m2023-06-01 → 2023-08-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥333m2022-06-01 → 2023-05-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥111m2022-06-01 → 2022-08-31Cons.Profit loss attributable to owners of parent
Net income¥127m2023-06-01 → 2023-08-31Cons.Profit loss
Net income¥114m2022-06-01 → 2022-08-31Cons.Profit loss
Total assets¥23.6bnat 2023-08-31Cons.Assets
Total assets¥23.4bnat 2023-05-31Cons.Assets
Total assets¥23.2bnat 2022-08-31Cons.Total assets (5-year summary)
Total liabilities¥16.6bnat 2023-08-31Cons.Liabilities
Total liabilities¥16.4bnat 2023-05-31Cons.Liabilities
Net assets / equity¥7.0bnat 2023-08-31Cons.Net assets
Net assets / equity¥7.0bnat 2023-05-31Cons.Net assets
Net assets / equity¥6.7bnat 2022-08-31Cons.Net assets (5-year summary)
Cash and deposits¥4.9bnat 2023-08-31Cons.Cash and deposits
Cash and deposits¥4.7bnat 2023-05-31Cons.Cash and deposits
EPS (basic)¥13.112023-06-01 → 2023-08-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥35.452022-06-01 → 2023-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥11.882022-06-01 → 2022-08-31Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥9.932023-06-01 → 2023-08-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥26.892022-06-01 → 2023-05-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥8.992022-06-01 → 2022-08-31Cons.Diluted earnings per share (5-year summary)
Equity ratio28.3%at 2023-08-31Cons.Equity to asset ratio (5-year summary)
Equity ratio28.5%at 2023-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio27.6%at 2022-08-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 44
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-06-01 → 2023-08-31¥185m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-06-01 → 2023-08-31¥185m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-06-01 → 2023-08-31¥0
Reconciling Itemsreconcilingsegment profit2023-06-01 → 2023-08-31−¥78m
jpcrp040300-q1r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue2023-06-01 → 2023-08-31¥2.1bn
jpcrp040300-q1r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue external2023-06-01 → 2023-08-31¥2.1bn
jpcrp040300-q1r_E05379-000Cosmetic Drug And Convenience Storereportable segmentsegment profit2023-06-01 → 2023-08-31−¥9m
jpcrp040300-q1r_E05379-000Custody Of Medical Documentsreportable segmentrevenue2023-06-01 → 2023-08-31¥155m
jpcrp040300-q1r_E05379-000Custody Of Medical Documentsreportable segmentrevenue external2023-06-01 → 2023-08-31¥155m
jpcrp040300-q1r_E05379-000Custody Of Medical Documentsreportable segmentsegment profit2023-06-01 → 2023-08-31¥11m
jpcrp040300-q1r_E05379-000Dispensing Pharmacyreportable segmentrevenue2023-06-01 → 2023-08-31¥10.9bn
jpcrp040300-q1r_E05379-000Dispensing Pharmacyreportable segmentrevenue external2023-06-01 → 2023-08-31¥10.9bn
jpcrp040300-q1r_E05379-000Dispensing Pharmacyreportable segmentsegment profit2023-06-01 → 2023-08-31¥379m
jpcrp040300-q1r_E05379-000Medical Mallreportable segmentrevenue2023-06-01 → 2023-08-31¥126m
jpcrp040300-q1r_E05379-000Medical Mallreportable segmentrevenue external2023-06-01 → 2023-08-31¥126m
jpcrp040300-q1r_E05379-000Medical Mallreportable segmentsegment profit2023-06-01 → 2023-08-31¥27m
—segment totalrevenue2023-06-01 → 2023-08-31¥13.3bn
—segment totalrevenue external2023-06-01 → 2023-08-31¥13.3bn
—segment totalsegment profit2023-06-01 → 2023-08-31¥408m
Total Of Reportable Segments And Otherssegment totalrevenue2023-06-01 → 2023-08-31¥13.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-06-01 → 2023-08-31¥13.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-06-01 → 2023-08-31¥409m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-06-01 → 2022-08-31¥204m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-06-01 → 2022-08-31¥204m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-06-01 → 2022-08-31¥21m
Reconciling Itemsreconcilingsegment profit2022-06-01 → 2022-08-31−¥75m
jpcrp040300-q1r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue2022-06-01 → 2022-08-31¥2.0bn
jpcrp040300-q1r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue external2022-06-01 → 2022-08-31¥2.0bn
jpcrp040300-q1r_E05379-000Cosmetic Drug And Convenience Storereportable segmentsegment profit2022-06-01 → 2022-08-31−¥35m
jpcrp040300-q1r_E05379-000Custody Of Medical Documentsreportable segmentrevenue2022-06-01 → 2022-08-31¥169m
jpcrp040300-q1r_E05379-000Custody Of Medical Documentsreportable segmentrevenue external2022-06-01 → 2022-08-31¥169m
jpcrp040300-q1r_E05379-000Custody Of Medical Documentsreportable segmentsegment profit2022-06-01 → 2022-08-31¥20m
jpcrp040300-q1r_E05379-000Dispensing Pharmacyreportable segmentrevenue2022-06-01 → 2022-08-31¥10.4bn
jpcrp040300-q1r_E05379-000Dispensing Pharmacyreportable segmentrevenue external2022-06-01 → 2022-08-31¥10.4bn
jpcrp040300-q1r_E05379-000Dispensing Pharmacyreportable segmentsegment profit2022-06-01 → 2022-08-31¥398m
jpcrp040300-q1r_E05379-000Medical Mallreportable segmentrevenue2022-06-01 → 2022-08-31¥126m
jpcrp040300-q1r_E05379-000Medical Mallreportable segmentrevenue external2022-06-01 → 2022-08-31¥126m
jpcrp040300-q1r_E05379-000Medical Mallreportable segmentsegment profit2022-06-01 → 2022-08-31¥19m
—segment totalrevenue2022-06-01 → 2022-08-31¥12.7bn
—segment totalrevenue external2022-06-01 → 2022-08-31¥12.7bn
—segment totalsegment profit2022-06-01 → 2022-08-31¥402m
Total Of Reportable Segments And Otherssegment totalrevenue2022-06-01 → 2022-08-31¥12.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-06-01 → 2022-08-31¥12.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-06-01 → 2022-08-31¥424m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 375
ItemContextValueUnit
Cost of salesPrior1YTDDuration10763000000JPY
Cost of salesCurrentYTDDuration11341000000JPY
Gross profitPrior1YTDDuration2098000000JPY
Gross profitCurrentYTDDuration2130000000JPY
Selling general and administrative expensesPrior1YTDDuration1749000000JPY
Selling general and administrative expensesCurrentYTDDuration1799000000JPY
Operating incomePrior1YTDDuration348000000JPY
Operating incomeCurrentYTDDuration331000000JPY
Interest income noiPrior1YTDDuration0JPY
Interest income noiCurrentYTDDuration0JPY
Dividends income noiPrior1YTDDuration0JPY
Dividends income noiCurrentYTDDuration0JPY
Commission fee noiPrior1YTDDuration5000000JPY
Commission fee noiCurrentYTDDuration6000000JPY
Rent income noiPrior1YTDDuration3000000JPY
Rent income noiCurrentYTDDuration4000000JPY
Other noiPrior1YTDDuration5000000JPY
Other noiCurrentYTDDuration6000000JPY
Non operating incomePrior1YTDDuration16000000JPY
Non operating incomeCurrentYTDDuration18000000JPY
Interest expenses noePrior1YTDDuration14000000JPY
Interest expenses noeCurrentYTDDuration13000000JPY
Rent cost noePrior1YTDDuration2000000JPY
Rent cost noeCurrentYTDDuration2000000JPY
Other noePrior1YTDDuration6000000JPY
Other noeCurrentYTDDuration1000000JPY
Non operating expensesPrior1YTDDuration23000000JPY
Non operating expensesCurrentYTDDuration17000000JPY
Ordinary incomePrior1YTDDuration341000000JPY
Ordinary incomeCurrentYTDDuration331000000JPY
Subsidy eiPrior1YTDDuration5000000JPY
Subsidy eiCurrentYTDDuration16000000JPY
Extraordinary incomePrior1YTDDuration5000000JPY
Extraordinary incomeCurrentYTDDuration16000000JPY
Loss on sales of noncurrent assets elPrior1YTDDuration2000000JPY
Loss on sales of noncurrent assets elCurrentYTDDuration－JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration21000000JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration0JPY
Loss on reduction of noncurrent assets elPrior1YTDDuration5000000JPY
Loss on reduction of noncurrent assets elCurrentYTDDuration13000000JPY
Provision of allowance for doubtful accounts elPrior1YTDDuration－JPY
Provision of allowance for doubtful accounts elCurrentYTDDuration22000000JPY
Extraordinary lossPrior1YTDDuration28000000JPY
Extraordinary lossCurrentYTDDuration35000000JPY
Income before income taxesPrior1YTDDuration318000000JPY
Income before income taxesCurrentYTDDuration312000000JPY
Income taxesPrior1YTDDuration203000000JPY
Income taxesCurrentYTDDuration185000000JPY
Profit lossPrior1YTDDuration114000000JPY
Profit lossCurrentYTDDuration127000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-05-31pass rounding
balance sheet identityconsolidated 2023-08-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-05-31pass
statement vs summary · net assetsconsolidated 2023-08-31pass
statement vs summary · net income attributable to parentconsolidated 2022-06-01/2022-08-31pass
statement vs summary · net income attributable to parentconsolidated 2023-06-01/2023-08-31pass
statement vs summary · revenueconsolidated 2022-06-01/2022-08-31pass
statement vs summary · revenueconsolidated 2023-06-01/2023-08-31pass
statement vs summary · total assetsconsolidated 2023-05-31pass
statement vs summary · total assetsconsolidated 2023-08-31pass